文献速递前列腺癌

无前列腺癌男性前列腺特异性抗原水平的种族差异:一项系统综述

Ethnic differences in prostate-specific antigen levels in men without prostate cancer: a systematic review.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2022-12-01

该系统综述纳入13项研究共654197名40岁及以上无前列腺癌男性,比较不同种族间PSA水平。结果显示黑人男性PSA水平高于白人男性,西班牙裔男性与白人男性相似且低于黑人男性。作者指出PSA对前列腺癌的诊断准确性在不同种族间尚不明确,现行PSA解读指南未考虑种族因素。

要点

  • 黑人无前列腺癌男性PSA水平高于白人及西班牙裔男性。
  • 西班牙裔男性PSA水平与白人男性相似,低于黑人男性。
  • 现行PSA解读指南未考虑种族因素,诊断准确性未知。

核心结论

  • 无前列腺癌的黑人男性PSA水平高于白人及西班牙裔男性,这与黑人男性前列腺癌诊断率较高相一致。
  • PSA对前列腺癌的诊断准确性在不同种族间尚不明确,现行PSA检测解读指南未考虑种族因素。
  • 未来研究需确定黑人男性是否与白人男性有相似的临床显著前列腺癌诊断率,或PSA升高是否导致黑人男性前列腺癌过度诊断。

研究设计与样本

  • 系统综述,检索PubMed和Embase,纳入报告至少两个种族无前列腺癌诊断或症状男性的PSA水平的研究。
  • 共纳入13项研究,654197名40岁及以上男性;按种族分:白人536201(82%)、黑人38287(6%)、亚洲人38232(6%)、太平洋岛民18029(3%)、毛利人13614(2%)、西班牙裔8885(1%)、其他949(<1%)。
  • 采用改编的纽卡斯尔-渥太华量表评估偏倚风险和研究质量;因所纳入研究报告的PSA测量指标和方法存在异质性,采用叙述性综合进行数据分析。

主要发现

  • 黑人男性PSA水平高于白人男性。
  • 西班牙裔男性PSA水平与白人男性相似,且低于黑人男性。

临床怎么用

  • 作者认为,未来研究需确定黑人男性是否与白人男性有相似的临床显著前列腺癌诊断率,或PSA升高是否导致黑人男性前列腺癌过度诊断。

局限性

  • 因所纳入研究报告的PSA测量指标和方法存在异质性,采用叙述性综合进行数据分析。
  • PSA对前列腺癌的诊断准确性在不同种族间尚不明确。
  • 现行PSA检测解读指南未考虑种族因素。
  • 未来研究需确定黑人男性是否与白人男性有相似的临床显著前列腺癌诊断率,或PSA升高是否导致黑人男性前列腺癌过度诊断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Black men are twice as likely to be diagnosed with prostate cancer than White men. Raised prostate-specific antigen (PSA) levels can indicate an increased risk of prostate cancer, however it is not known whether PSA levels differ for men of different ethnic groups. METHODS: PubMed and Embase were searched to identify studies that reported levels of PSA for men of at least two ethnic groups without a prostate cancer diagnosis or symptoms suggestive of prostate cancer. An adaptation of the Newcastle-Ottawa scale was used to assess risk of bias and study quality. Findings were stratified into the following broad ethnic groups: White, Black, Asian, Hispanic, and Other. Data were analysed in a narrative synthesis due to the heterogeneity of reported PSA measures and methods in the included studies. RESULTS: A total of 654 197 males from 13 studies were included. By ethnicity, this included 536 201 White (82%), 38 287 Black (6%), 38 232 Asian (6%), 18 029 Pacific Island (3%), 13 614 Maori (2%), 8 885 Hispanic (1%), and 949 Other (<1%) men aged ≥40 years old. Black men had higher PSA levels than White men, and Hispanic men had similar levels to White men and lower levels than Black men. CONCLUSIONS: Black men without prostate cancer have higher PSA levels than White or Hispanic men, which reflects the higher rates of prostate cancer diagnosis in Black men. Despite that, the diagnostic accuracy of PSA for prostate cancer for men of different ethnic groups is unknown, and current guidance for PSA test interpretation does not account for ethnicity. Future research needs to determine whether Black men are diagnosed with similar rates of clinically significant prostate cancer to White men, or whether raised PSA levels are contributing to overdiagnosis of prostate cancer in Black men.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Barlow M, Down L, Mounce LTA, et al. Ethnic differences in prostate-specific antigen levels in men without prostate cancer: a systematic review. Prostate Cancer Prostatic Dis. 2022. PMID: 36456698. doi:10.1038/s41391-022-00613-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。